Reducing wound scarring with antibodies to growth factors

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/395 (2006.01) A61K 31/70 (2006.01) A61K 38/18 (2006.01) A61K 38/19 (2006.01)

Patent

CA 2105652

A composition for use in the treatment of wounds to inhibit scar tissue formation during healing is disclosed, comprising an effective activity-inhibiting amount of a growth factor neutralising agent or agents specific against only fibrotic growth factors together with a pharmaceutically acceptable carrier. The method of preparation of said composition and method of administering the composition to a host suffering from tissue wounding is also disclosed.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Reducing wound scarring with antibodies to growth factors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Reducing wound scarring with antibodies to growth factors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Reducing wound scarring with antibodies to growth factors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1809820

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.